
The Architecture of Biological Routing: How Programmable Therapeutics are Rewiring Pharmaceutical Economics
The convergence of in vivo gene editing, AI-driven target discovery, and personalized mRNA platforms has triggered a structural rupture in pharmaceuti...
Read Full Story →



